Exploration of the pathogenesis of polycystic ovary syndrome based on gut microbiota: A review

被引:5
|
作者
Guo, Hua [1 ]
Luo, Jing [1 ]
Lin, Hanmei [2 ,3 ]
机构
[1] Guangxi Univ Tradit Chinese Med, Grad Sch, Nanning, Peoples R China
[2] Guangxi Univ Tradit Chinese Med, Affiliated Hosp 1, Dept Gynaecol, Nanning, Guangxi Zhuang, Peoples R China
[3] 89-9 Dongge Rd, Nanning 530000, Guangxi Zhuang, Peoples R China
基金
中国国家自然科学基金;
关键词
gut microbiota; hyperandrogenism; insulin resistance; neuroendocrine dysfunction; polycystic ovary syndrome; PROTEIN-COUPLED RECEPTOR; CHAIN FATTY-ACIDS; METAGENOMIC ANALYSIS; INSULIN; OBESITY; WOMEN;
D O I
10.1097/MD.0000000000036075
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Polycystic ovary syndrome (PCOS) is a complex disorde7r influenced by genetic, neuroendocrine, metabolic, environmental, and lifestyle factors. This paper delves into the increasingly recognized role of gut microbiota dysbiosis in the onset and progression of PCOS. Utilizing advances in next-generation sequencing and metabolomics, the research examines the intricate interaction between the gut microbiota and the central nervous system via the gut-brain axis. The paper highlights how disruptions in gut microbiota contribute significantly to PCOS by modulating the release of gut-brain peptides and activating inflammatory pathways. Through such mechanisms, gut microbiota dysbiosis is implicated in hyperandrogenism, insulin resistance, chronic inflammation, and metabolic disorders associated with PCOS. While the relationship between gut microbiota and PCOS has begun to be elucidated, this paper underscores the need for further research to identify specific bacterial strains and their metabolic byproducts as potential therapeutic targets. Therefore, comprehensive studies are urgently needed to understand and fundamentally treat the pathophysiological processes of PCOS, offering valuable insights for future treatment and prevention strategies.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Gut microbiota and risk of polycystic ovary syndrome: Insights from Mendelian randomization
    Li, Jing-wei
    Chen, Yu-zhi
    Zhang, Yu
    Zeng, Li-hua
    Li, Kai-wei
    Xie, Bao-zhen
    Luo, Song-ping
    Gao, Jie
    HELIYON, 2023, 9 (12)
  • [32] Gut microbiota dysbiosis in polycystic ovary syndrome: Mechanisms of progression and clinical applications
    Sun, Yan
    Gao, Shouyang
    Ye, Cong
    Zhao, Weiliang
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [33] Gut microbiota dysbiosis in polycystic ovary syndrome: association with obesity - a preliminary report
    Liang, Yuanjiao
    Ming, Qi
    Liang, Jinlan
    Zhang, Yan
    Zhang, Hong
    Shen, Tao
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2020, 98 (11) : 803 - 809
  • [34] Gut Microbiota and the Polycystic Ovary Syndrome: Influence of Sex, Sex Hormones, and Obesity
    Insenser, Maria
    Murri, Mora
    del Campo, Rosa
    Angeles Martinez-Garcia, M.
    Fernandez-Duran, Elena
    Escobar-Morreale, Hector F.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (07): : 2552 - 2562
  • [35] Gut microbiota in adolescent girls with polycystic ovary syndrome: Effects of randomized treatments
    Garcia-Beltran, Cristina
    Malpique, Rita
    Carbonetto, Belen
    Gonzalez-Torres, Pedro
    Henares, Desiree
    Brotons, Pedro
    Munoz-Almagro, Carmen
    Lopez-Bermejo, Abel
    de Zegher, Francis
    Ibanez, Lourdes
    PEDIATRIC OBESITY, 2021, 16 (04):
  • [36] Correlation Between Fecal Metabolomics and Gut Microbiota in Obesity and Polycystic Ovary Syndrome
    Zhou, Ling
    Ni, Zhexin
    Yu, Jin
    Cheng, Wen
    Cai, Zailong
    Yu, Chaoqin
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [37] PATHOGENESIS AND TREATMENT OF POLYCYSTIC OVARY SYNDROME
    MCKENNA, TJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (09): : 558 - 562
  • [38] Pathogenesis of anovulation in polycystic ovary syndrome
    Lanzone, A
    Ciampelli, M
    Fulghesu, AM
    Cucinelli, F
    Muzj, G
    Pierro, E
    Guido, M
    Soranna, L
    Belosi, C
    Perri, C
    Serri, F
    ROLE OF LUTEINIZING HORMONE IN FOLLICULOGENESIS AND OVULATION INDUCTION, 1999, : 115 - 133
  • [39] Polycystic ovary syndrome: Etiology and pathogenesis
    Matalliotakis I.
    Kourtis A.
    Koukoura O.
    Panidis D.
    Archives of Gynecology and Obstetrics, 2006, 274 (4) : 187 - 197
  • [40] THE POLYCYSTIC OVARY SYNDROME - PATHOGENESIS AND TREATMENT
    BARNES, R
    ROSENFIELD, RL
    ANNALS OF INTERNAL MEDICINE, 1989, 110 (05) : 386 - 399